| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myosin Heavy Chains | 69 | 2024 | 173 | 12.900 |
Why?
|
| Myocytes, Cardiac | 36 | 2024 | 495 | 7.470 |
Why?
|
| Heart | 38 | 2024 | 639 | 6.540 |
Why?
|
| Myocardium | 65 | 2024 | 973 | 6.540 |
Why?
|
| Myosins | 59 | 2024 | 133 | 6.210 |
Why?
|
| Boidae | 8 | 2024 | 20 | 5.090 |
Why?
|
| Cardiomyopathy, Hypertrophic | 25 | 2022 | 131 | 4.800 |
Why?
|
| Cardiomegaly | 19 | 2024 | 170 | 4.460 |
Why?
|
| Cardiac Myosins | 15 | 2024 | 30 | 3.920 |
Why?
|
| Ventricular Myosins | 12 | 2024 | 36 | 3.500 |
Why?
|
| Adaptation, Physiological | 16 | 2024 | 515 | 3.270 |
Why?
|
| Muscle, Skeletal | 43 | 2024 | 1640 | 3.220 |
Why?
|
| Animals | 258 | 2024 | 34600 | 3.030 |
Why?
|
| Cardiomyopathies | 12 | 2024 | 337 | 2.800 |
Why?
|
| Heart Diseases | 11 | 2021 | 347 | 2.770 |
Why?
|
| Sex Characteristics | 16 | 2022 | 727 | 2.480 |
Why?
|
| Mice | 134 | 2024 | 16644 | 2.340 |
Why?
|
| MicroRNAs | 9 | 2023 | 677 | 2.340 |
Why?
|
| Cardiomyopathy, Dilated | 6 | 2022 | 377 | 2.020 |
Why?
|
| Estrogens | 10 | 2024 | 354 | 2.020 |
Why?
|
| Mutation | 35 | 2024 | 3700 | 1.980 |
Why?
|
| Gene Expression Regulation | 34 | 2022 | 2508 | 1.980 |
Why?
|
| Myocardial Contraction | 14 | 2021 | 331 | 1.820 |
Why?
|
| Rats | 78 | 2021 | 5173 | 1.800 |
Why?
|
| Actins | 24 | 2024 | 402 | 1.790 |
Why?
|
| Sarcomeres | 19 | 2022 | 92 | 1.780 |
Why?
|
| Distal Myopathies | 4 | 2024 | 9 | 1.750 |
Why?
|
| Ventricular Remodeling | 6 | 2024 | 258 | 1.740 |
Why?
|
| Myosin Type II | 5 | 2023 | 16 | 1.700 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 8 | 2016 | 16 | 1.670 |
Why?
|
| Protein Isoforms | 24 | 2023 | 379 | 1.590 |
Why?
|
| Postprandial Period | 6 | 2024 | 103 | 1.570 |
Why?
|
| Muscle Contraction | 12 | 2024 | 421 | 1.540 |
Why?
|
| Myosin Subfragments | 17 | 2016 | 21 | 1.390 |
Why?
|
| Disease Models, Animal | 30 | 2023 | 3953 | 1.350 |
Why?
|
| Proline | 3 | 2024 | 78 | 1.350 |
Why?
|
| Phytoestrogens | 5 | 2014 | 17 | 1.340 |
Why?
|
| Adenosine Triphosphatases | 9 | 2024 | 161 | 1.300 |
Why?
|
| Amino Acid Substitution | 9 | 2024 | 281 | 1.300 |
Why?
|
| Hypertrophy, Left Ventricular | 4 | 2022 | 127 | 1.230 |
Why?
|
| Heart Ventricles | 16 | 2021 | 768 | 1.210 |
Why?
|
| Mice, Transgenic | 33 | 2024 | 2079 | 1.210 |
Why?
|
| Cell Differentiation | 15 | 2021 | 1901 | 1.190 |
Why?
|
| Myofibroblasts | 6 | 2022 | 128 | 1.190 |
Why?
|
| Physical Conditioning, Animal | 10 | 2013 | 229 | 1.170 |
Why?
|
| Cardiovascular Diseases | 9 | 2021 | 2024 | 1.140 |
Why?
|
| Gene Transfer Techniques | 8 | 2003 | 162 | 1.140 |
Why?
|
| Isoproterenol | 6 | 2022 | 107 | 1.120 |
Why?
|
| Fibroblasts | 10 | 2021 | 939 | 1.100 |
Why?
|
| Motor Activity | 9 | 2017 | 669 | 1.100 |
Why?
|
| Cell Line | 38 | 2023 | 2737 | 1.080 |
Why?
|
| Molecular Sequence Data | 50 | 2015 | 2819 | 1.070 |
Why?
|
| Fibrosis | 12 | 2022 | 522 | 1.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 8 | 2013 | 421 | 1.040 |
Why?
|
| DNA | 41 | 2016 | 1392 | 1.030 |
Why?
|
| Plasmids | 16 | 2009 | 357 | 1.030 |
Why?
|
| Signal Transduction | 27 | 2024 | 4838 | 1.020 |
Why?
|
| Promoter Regions, Genetic | 21 | 2015 | 1200 | 1.010 |
Why?
|
| Calcineurin | 6 | 2013 | 91 | 1.000 |
Why?
|
| Gene Expression | 29 | 2022 | 1462 | 0.990 |
Why?
|
| Muscle Fibers, Skeletal | 10 | 2020 | 190 | 0.980 |
Why?
|
| Base Sequence | 55 | 2012 | 2135 | 0.980 |
Why?
|
| RNA, Messenger | 35 | 2021 | 2676 | 0.960 |
Why?
|
| Cells, Cultured | 37 | 2022 | 4010 | 0.960 |
Why?
|
| Transcription, Genetic | 18 | 2015 | 1403 | 0.950 |
Why?
|
| Adenosine Triphosphate | 11 | 2021 | 471 | 0.940 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2024 | 21 | 0.920 |
Why?
|
| Glycogen Synthase Kinase 3 | 6 | 2017 | 79 | 0.920 |
Why?
|
| Heart Failure | 12 | 2023 | 2158 | 0.900 |
Why?
|
| Troponin T | 9 | 2009 | 57 | 0.900 |
Why?
|
| Physical Exertion | 4 | 2014 | 212 | 0.900 |
Why?
|
| Transcription Factors | 14 | 2015 | 1632 | 0.900 |
Why?
|
| Cardiovascular Physiological Phenomena | 5 | 2017 | 44 | 0.900 |
Why?
|
| Humans | 155 | 2024 | 129128 | 0.890 |
Why?
|
| Genes | 21 | 1994 | 226 | 0.880 |
Why?
|
| Transfection | 20 | 2012 | 896 | 0.880 |
Why?
|
| Pyrroles | 2 | 2015 | 192 | 0.880 |
Why?
|
| Muscle Cells | 3 | 2018 | 39 | 0.870 |
Why?
|
| Transcriptome | 7 | 2024 | 883 | 0.860 |
Why?
|
| Sex Factors | 10 | 2024 | 1953 | 0.850 |
Why?
|
| DNA-Binding Proteins | 12 | 2012 | 1423 | 0.840 |
Why?
|
| Mice, Inbred C57BL | 23 | 2019 | 5284 | 0.840 |
Why?
|
| Aging | 8 | 2018 | 1772 | 0.840 |
Why?
|
| Gene Expression Profiling | 6 | 2014 | 1689 | 0.840 |
Why?
|
| Mammals | 8 | 2022 | 269 | 0.830 |
Why?
|
| Heart Valves | 9 | 2014 | 41 | 0.830 |
Why?
|
| Gonadal Steroid Hormones | 5 | 2024 | 132 | 0.820 |
Why?
|
| Male | 78 | 2024 | 63202 | 0.820 |
Why?
|
| Myogenic Regulatory Factors | 7 | 2012 | 56 | 0.810 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2020 | 155 | 0.790 |
Why?
|
| Myoblasts | 3 | 2019 | 80 | 0.780 |
Why?
|
| RNA, Long Noncoding | 2 | 2022 | 178 | 0.780 |
Why?
|
| Integrases | 3 | 2015 | 118 | 0.770 |
Why?
|
| Mutation, Missense | 7 | 2024 | 318 | 0.770 |
Why?
|
| Indoles | 2 | 2015 | 372 | 0.760 |
Why?
|
| Recombinant Proteins | 14 | 2023 | 1284 | 0.760 |
Why?
|
| Epigenesis, Genetic | 2 | 2024 | 616 | 0.740 |
Why?
|
| Point Mutation | 4 | 2018 | 224 | 0.740 |
Why?
|
| Female | 67 | 2024 | 68518 | 0.730 |
Why?
|
| Membrane Proteins | 7 | 2020 | 1109 | 0.730 |
Why?
|
| Rats, Sprague-Dawley | 19 | 2021 | 2245 | 0.720 |
Why?
|
| Adenoviridae | 10 | 2011 | 190 | 0.710 |
Why?
|
| Carrier Proteins | 8 | 2022 | 732 | 0.700 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2021 | 126 | 0.700 |
Why?
|
| Alternative Splicing | 4 | 2023 | 218 | 0.690 |
Why?
|
| Models, Biological | 7 | 2017 | 1695 | 0.690 |
Why?
|
| Neoplasms, Experimental | 2 | 2011 | 169 | 0.680 |
Why?
|
| Paracrine Communication | 1 | 2020 | 61 | 0.680 |
Why?
|
| Diet | 4 | 2014 | 1204 | 0.680 |
Why?
|
| Muscle Development | 6 | 2015 | 103 | 0.680 |
Why?
|
| Genetic Vectors | 14 | 2009 | 311 | 0.680 |
Why?
|
| Amino Acid Sequence | 33 | 2021 | 2041 | 0.670 |
Why?
|
| Genetic Therapy | 14 | 2009 | 293 | 0.660 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2019 | 22 | 0.650 |
Why?
|
| Hearing Loss | 1 | 2023 | 210 | 0.650 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2012 | 79 | 0.630 |
Why?
|
| Kinetics | 10 | 2023 | 1617 | 0.630 |
Why?
|
| Estrogen Receptor alpha | 2 | 2019 | 134 | 0.630 |
Why?
|
| Transgenes | 6 | 2009 | 177 | 0.620 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2017 | 175 | 0.610 |
Why?
|
| Pregnancy Complications | 2 | 2014 | 491 | 0.610 |
Why?
|
| Hydrogels | 7 | 2019 | 636 | 0.610 |
Why?
|
| Cardiotoxicity | 2 | 2015 | 33 | 0.610 |
Why?
|
| Phenotype | 21 | 2020 | 3058 | 0.610 |
Why?
|
| Mechanical Phenomena | 1 | 2019 | 83 | 0.600 |
Why?
|
| Muscles | 18 | 2019 | 323 | 0.600 |
Why?
|
| Interleukin-10 | 8 | 2009 | 299 | 0.580 |
Why?
|
| Cyclin D2 | 1 | 2017 | 5 | 0.580 |
Why?
|
| Exons | 3 | 2010 | 338 | 0.570 |
Why?
|
| Calcium Signaling | 4 | 2004 | 235 | 0.570 |
Why?
|
| Biocompatible Materials | 5 | 2019 | 398 | 0.560 |
Why?
|
| MAP Kinase Signaling System | 5 | 2019 | 303 | 0.560 |
Why?
|
| Phosphorylation | 9 | 2017 | 1687 | 0.530 |
Why?
|
| Muscular Dystrophy, Animal | 3 | 2023 | 8 | 0.530 |
Why?
|
| Craniofacial Dysostosis | 1 | 2016 | 3 | 0.520 |
Why?
|
| Cloning, Molecular | 22 | 1999 | 522 | 0.520 |
Why?
|
| Cytoskeletal Proteins | 2 | 2016 | 142 | 0.510 |
Why?
|
| Estrogen Receptor beta | 1 | 2016 | 35 | 0.510 |
Why?
|
| MyoD Protein | 3 | 2012 | 32 | 0.500 |
Why?
|
| Injections, Spinal | 9 | 2009 | 106 | 0.500 |
Why?
|
| Muscle Proteins | 6 | 2022 | 229 | 0.490 |
Why?
|
| Organ Size | 12 | 2009 | 441 | 0.490 |
Why?
|
| Autophagy | 2 | 2024 | 267 | 0.490 |
Why?
|
| Liver | 7 | 2022 | 1833 | 0.480 |
Why?
|
| Extracellular Matrix | 9 | 2021 | 498 | 0.480 |
Why?
|
| Cardiotoxins | 1 | 2014 | 4 | 0.470 |
Why?
|
| Recombination, Genetic | 3 | 2007 | 189 | 0.470 |
Why?
|
| Feedback, Physiological | 1 | 2015 | 74 | 0.470 |
Why?
|
| Pregnancy | 7 | 2018 | 6375 | 0.460 |
Why?
|
| Exercise | 6 | 2023 | 1950 | 0.450 |
Why?
|
| COS Cells | 7 | 2023 | 184 | 0.450 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 330 | 0.450 |
Why?
|
| Physical Endurance | 3 | 2013 | 269 | 0.450 |
Why?
|
| Calcium | 10 | 2024 | 1180 | 0.440 |
Why?
|
| Myofibrils | 4 | 2024 | 50 | 0.440 |
Why?
|
| Mutant Proteins | 3 | 2015 | 98 | 0.440 |
Why?
|
| YY1 Transcription Factor | 4 | 2006 | 28 | 0.430 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2012 | 313 | 0.430 |
Why?
|
| Actin Cytoskeleton | 6 | 2019 | 101 | 0.430 |
Why?
|
| Genetics, Medical | 1 | 2013 | 24 | 0.420 |
Why?
|
| Aortic Valve | 8 | 2022 | 350 | 0.420 |
Why?
|
| Myocarditis | 3 | 2012 | 98 | 0.420 |
Why?
|
| Molecular Motor Proteins | 2 | 2012 | 35 | 0.420 |
Why?
|
| Science | 1 | 2014 | 52 | 0.420 |
Why?
|
| Animals, Newborn | 13 | 2012 | 805 | 0.420 |
Why?
|
| Blotting, Western | 7 | 2021 | 1169 | 0.410 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2004 | 179 | 0.400 |
Why?
|
| Research | 4 | 2014 | 410 | 0.400 |
Why?
|
| Fasting | 2 | 2011 | 264 | 0.400 |
Why?
|
| RNA | 11 | 2021 | 883 | 0.390 |
Why?
|
| Ikaros Transcription Factor | 1 | 2012 | 21 | 0.390 |
Why?
|
| Ventricular Function, Left | 3 | 2020 | 528 | 0.390 |
Why?
|
| Proteolysis | 1 | 2012 | 162 | 0.380 |
Why?
|
| RNA, Transfer | 3 | 2003 | 130 | 0.380 |
Why?
|
| Soybean Proteins | 2 | 2014 | 14 | 0.370 |
Why?
|
| Nucleic Acid Hybridization | 16 | 2000 | 188 | 0.370 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2007 | 87 | 0.370 |
Why?
|
| Apoptosis | 5 | 2014 | 2438 | 0.370 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 5 | 2012 | 67 | 0.360 |
Why?
|
| Quality of Life | 1 | 2023 | 2694 | 0.360 |
Why?
|
| Urea | 1 | 2011 | 75 | 0.360 |
Why?
|
| Atrial Natriuretic Factor | 6 | 2006 | 56 | 0.350 |
Why?
|
| Cachexia | 1 | 2011 | 60 | 0.350 |
Why?
|
| Stress, Physiological | 1 | 2014 | 412 | 0.350 |
Why?
|
| Carrier State | 2 | 2021 | 60 | 0.350 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2010 | 19 | 0.350 |
Why?
|
| Amino Acids | 2 | 2015 | 474 | 0.350 |
Why?
|
| Mice, Knockout | 10 | 2022 | 2765 | 0.350 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2006 | 818 | 0.350 |
Why?
|
| Genetic Variation | 4 | 2006 | 934 | 0.340 |
Why?
|
| Genes, Reporter | 8 | 2006 | 266 | 0.340 |
Why?
|
| Echocardiography | 5 | 2017 | 627 | 0.340 |
Why?
|
| Hypertrophy | 6 | 2022 | 115 | 0.340 |
Why?
|
| Models, Animal | 3 | 2024 | 367 | 0.340 |
Why?
|
| Microscopy, Electron | 12 | 2009 | 417 | 0.340 |
Why?
|
| Curriculum | 2 | 2014 | 925 | 0.330 |
Why?
|
| Calcineurin Inhibitors | 3 | 2013 | 59 | 0.330 |
Why?
|
| Escherichia coli | 10 | 1997 | 771 | 0.330 |
Why?
|
| Introns | 2 | 2010 | 249 | 0.330 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2009 | 31 | 0.330 |
Why?
|
| Myopathies, Nemaline | 1 | 2009 | 2 | 0.320 |
Why?
|
| Gene Library | 3 | 2007 | 116 | 0.320 |
Why?
|
| Mitochondria, Heart | 2 | 2016 | 92 | 0.320 |
Why?
|
| Interferon-gamma | 1 | 2012 | 762 | 0.320 |
Why?
|
| Heat-Shock Proteins, Small | 1 | 2008 | 2 | 0.320 |
Why?
|
| Myogenin | 2 | 2019 | 13 | 0.310 |
Why?
|
| Green Fluorescent Proteins | 2 | 2008 | 382 | 0.310 |
Why?
|
| CpG Islands | 1 | 2009 | 152 | 0.310 |
Why?
|
| Histone Deacetylases | 2 | 2011 | 209 | 0.310 |
Why?
|
| Multigene Family | 6 | 1999 | 198 | 0.310 |
Why?
|
| Fatty Acids | 1 | 2011 | 415 | 0.310 |
Why?
|
| Body Weight | 10 | 2021 | 932 | 0.300 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 872 | 0.300 |
Why?
|
| Cytokines | 4 | 2018 | 1987 | 0.300 |
Why?
|
| Serum Response Factor | 2 | 2006 | 31 | 0.300 |
Why?
|
| Codon, Terminator | 4 | 2003 | 21 | 0.300 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 568 | 0.300 |
Why?
|
| Myanmar | 2 | 2022 | 6 | 0.300 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 8 | 2002 | 37 | 0.290 |
Why?
|
| Myogenic Regulatory Factor 5 | 2 | 2006 | 6 | 0.290 |
Why?
|
| Alkaline Phosphatase | 1 | 2008 | 142 | 0.290 |
Why?
|
| Protein Structure, Secondary | 5 | 2015 | 338 | 0.290 |
Why?
|
| MEF2 Transcription Factors | 5 | 2006 | 62 | 0.290 |
Why?
|
| Attachment Sites, Microbiological | 1 | 2007 | 4 | 0.290 |
Why?
|
| Adrenergic beta-Agonists | 4 | 2021 | 129 | 0.290 |
Why?
|
| Protein Kinase C | 2 | 2006 | 253 | 0.280 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 10 | 1992 | 111 | 0.280 |
Why?
|
| Regeneration | 2 | 2012 | 175 | 0.280 |
Why?
|
| Genotype | 4 | 2021 | 1832 | 0.280 |
Why?
|
| Cathepsin D | 1 | 2007 | 17 | 0.280 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 4 | 2017 | 132 | 0.270 |
Why?
|
| Polyethylene Glycols | 5 | 2019 | 597 | 0.270 |
Why?
|
| Immunohistochemistry | 11 | 2022 | 1671 | 0.270 |
Why?
|
| Puerperal Disorders | 1 | 2007 | 30 | 0.270 |
Why?
|
| Feeding Behavior | 2 | 2010 | 618 | 0.270 |
Why?
|
| Desmin | 2 | 2003 | 24 | 0.270 |
Why?
|
| Calcium-Binding Proteins | 3 | 2006 | 211 | 0.270 |
Why?
|
| Prolactin | 1 | 2007 | 97 | 0.270 |
Why?
|
| Structure-Activity Relationship | 8 | 2015 | 531 | 0.260 |
Why?
|
| Binding Sites | 10 | 2013 | 1241 | 0.260 |
Why?
|
| Cellular Microenvironment | 2 | 2019 | 79 | 0.260 |
Why?
|
| Age Factors | 6 | 2010 | 3120 | 0.260 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2006 | 67 | 0.260 |
Why?
|
| Protein Structure, Tertiary | 7 | 2013 | 836 | 0.260 |
Why?
|
| Muscle, Smooth | 4 | 2009 | 145 | 0.260 |
Why?
|
| Sequence Homology, Nucleic Acid | 9 | 2010 | 150 | 0.260 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2006 | 181 | 0.250 |
Why?
|
| Chromosomes | 5 | 2021 | 101 | 0.250 |
Why?
|
| Animals, Genetically Modified | 2 | 2011 | 232 | 0.250 |
Why?
|
| Swine | 10 | 2022 | 745 | 0.250 |
Why?
|
| Mitochondria | 3 | 2019 | 854 | 0.250 |
Why?
|
| Oligonucleotide Probes | 5 | 2000 | 50 | 0.250 |
Why?
|
| Trans-Activators | 3 | 2012 | 381 | 0.250 |
Why?
|
| RNA Splicing | 1 | 2007 | 262 | 0.250 |
Why?
|
| Hydrolysis | 3 | 2016 | 185 | 0.240 |
Why?
|
| Angiotensin II | 2 | 2022 | 93 | 0.240 |
Why?
|
| Mice, Inbred Strains | 5 | 2016 | 402 | 0.240 |
Why?
|
| STAT3 Transcription Factor | 1 | 2007 | 190 | 0.240 |
Why?
|
| Dictyostelium | 5 | 1994 | 11 | 0.240 |
Why?
|
| Muscular Atrophy | 3 | 2015 | 79 | 0.240 |
Why?
|
| Stem Cells | 2 | 2013 | 579 | 0.240 |
Why?
|
| Tissue Distribution | 6 | 2010 | 291 | 0.230 |
Why?
|
| Antigens, Nuclear | 1 | 2004 | 20 | 0.230 |
Why?
|
| Nuclear Proteins | 3 | 2006 | 660 | 0.230 |
Why?
|
| Asymptomatic Infections | 2 | 2021 | 24 | 0.230 |
Why?
|
| Chickens | 4 | 2014 | 188 | 0.230 |
Why?
|
| Testosterone | 2 | 2024 | 379 | 0.230 |
Why?
|
| Protein Biosynthesis | 6 | 2012 | 397 | 0.230 |
Why?
|
| Stress Fibers | 1 | 2004 | 18 | 0.230 |
Why?
|
| Molecular Biology | 4 | 2014 | 55 | 0.230 |
Why?
|
| Biological Transport | 4 | 2015 | 394 | 0.230 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2012 | 634 | 0.230 |
Why?
|
| Suppression, Genetic | 2 | 2003 | 25 | 0.230 |
Why?
|
| Myosin Light Chains | 3 | 2019 | 27 | 0.230 |
Why?
|
| Protein Conformation | 5 | 2021 | 853 | 0.220 |
Why?
|
| Protein Kinases | 1 | 2006 | 309 | 0.220 |
Why?
|
| Alleles | 4 | 2018 | 845 | 0.220 |
Why?
|
| Adipose Tissue | 1 | 2008 | 592 | 0.220 |
Why?
|
| Pseudogenes | 4 | 1992 | 18 | 0.220 |
Why?
|
| Cell Proliferation | 6 | 2019 | 2347 | 0.220 |
Why?
|
| Hibernation | 3 | 2013 | 74 | 0.220 |
Why?
|
| Isoflavones | 1 | 2003 | 25 | 0.220 |
Why?
|
| NFATC Transcription Factors | 3 | 2013 | 79 | 0.220 |
Why?
|
| Genes, Dominant | 3 | 2006 | 91 | 0.210 |
Why?
|
| Disease Progression | 5 | 2021 | 2613 | 0.210 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2016 | 357 | 0.210 |
Why?
|
| Models, Molecular | 6 | 2018 | 1483 | 0.210 |
Why?
|
| Receptors, Estrogen | 3 | 2012 | 429 | 0.210 |
Why?
|
| Heart Valve Diseases | 2 | 2015 | 151 | 0.210 |
Why?
|
| In Vitro Techniques | 8 | 2014 | 1044 | 0.210 |
Why?
|
| Contractile Proteins | 2 | 1996 | 15 | 0.210 |
Why?
|
| Weightlessness | 1 | 2003 | 67 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 3 | 2012 | 773 | 0.210 |
Why?
|
| Chromosome Mapping | 12 | 2013 | 505 | 0.200 |
Why?
|
| Viral Load | 2 | 2021 | 450 | 0.200 |
Why?
|
| Saliva | 2 | 2021 | 207 | 0.200 |
Why?
|
| Adenosine Diphosphate | 4 | 2021 | 78 | 0.200 |
Why?
|
| Protein Binding | 9 | 2013 | 2106 | 0.200 |
Why?
|
| Weight Loss | 1 | 2008 | 724 | 0.200 |
Why?
|
| Mice, Mutant Strains | 5 | 2015 | 292 | 0.200 |
Why?
|
| Protein Aggregates | 1 | 2023 | 66 | 0.200 |
Why?
|
| Protein Transport | 2 | 2019 | 422 | 0.200 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2022 | 30 | 0.200 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2023 | 94 | 0.190 |
Why?
|
| Genes, X-Linked | 1 | 2022 | 18 | 0.190 |
Why?
|
| Biophysics | 2 | 2019 | 69 | 0.190 |
Why?
|
| X Chromosome Inactivation | 1 | 2022 | 23 | 0.190 |
Why?
|
| Cell Size | 3 | 2011 | 87 | 0.190 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2000 | 138 | 0.190 |
Why?
|
| Universities | 4 | 2021 | 402 | 0.190 |
Why?
|
| Protein Stability | 3 | 2015 | 161 | 0.190 |
Why?
|
| Cytoskeleton | 3 | 2003 | 180 | 0.190 |
Why?
|
| Ribonucleoproteins | 2 | 2001 | 87 | 0.190 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2021 | 217 | 0.190 |
Why?
|
| Luciferases | 5 | 2005 | 148 | 0.190 |
Why?
|
| DNA, Recombinant | 4 | 1995 | 46 | 0.180 |
Why?
|
| Atrophy | 2 | 2012 | 172 | 0.180 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2001 | 44 | 0.180 |
Why?
|
| Progesterone | 2 | 2013 | 244 | 0.180 |
Why?
|
| Cell Division | 3 | 2017 | 779 | 0.180 |
Why?
|
| Phenylephrine | 2 | 2015 | 72 | 0.180 |
Why?
|
| Intercellular Junctions | 2 | 1991 | 39 | 0.180 |
Why?
|
| Estradiol | 2 | 2016 | 497 | 0.180 |
Why?
|
| Enzyme Activation | 3 | 2012 | 799 | 0.180 |
Why?
|
| RNA, Transfer, Ser | 1 | 2000 | 4 | 0.170 |
Why?
|
| Protein Domains | 2 | 2021 | 252 | 0.170 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 3 | 2005 | 18 | 0.170 |
Why?
|
| Gestational Age | 4 | 2013 | 868 | 0.170 |
Why?
|
| Triglycerides | 2 | 2014 | 524 | 0.170 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2021 | 224 | 0.170 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 102 | 0.170 |
Why?
|
| DNA Transposable Elements | 5 | 2006 | 119 | 0.170 |
Why?
|
| Age of Onset | 2 | 2019 | 494 | 0.170 |
Why?
|
| Cadaver | 1 | 2021 | 330 | 0.170 |
Why?
|
| Time Factors | 9 | 2012 | 6518 | 0.170 |
Why?
|
| Polymerase Chain Reaction | 9 | 2011 | 1021 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 4 | 2011 | 1230 | 0.170 |
Why?
|
| Cardiac Output, Low | 1 | 2000 | 66 | 0.170 |
Why?
|
| Poly A | 6 | 1994 | 48 | 0.170 |
Why?
|
| Oxidation-Reduction | 4 | 2011 | 1002 | 0.160 |
Why?
|
| Acclimatization | 1 | 2001 | 160 | 0.160 |
Why?
|
| Transcription Initiation Site | 2 | 2012 | 43 | 0.160 |
Why?
|
| Anthracenes | 1 | 2019 | 31 | 0.160 |
Why?
|
| Capsules | 1 | 2019 | 37 | 0.160 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2020 | 111 | 0.160 |
Why?
|
| Serum | 1 | 2019 | 57 | 0.160 |
Why?
|
| Circular Dichroism | 2 | 2009 | 146 | 0.160 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2012 | 34 | 0.160 |
Why?
|
| Intracellular Space | 1 | 2019 | 71 | 0.160 |
Why?
|
| Troponin | 2 | 1998 | 50 | 0.160 |
Why?
|
| Energy Metabolism | 1 | 2024 | 836 | 0.150 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2012 | 358 | 0.150 |
Why?
|
| Evolution, Molecular | 2 | 2019 | 467 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 428 | 0.150 |
Why?
|
| HEK293 Cells | 3 | 2016 | 687 | 0.150 |
Why?
|
| Cell Survival | 3 | 2019 | 1077 | 0.150 |
Why?
|
| Cell Culture Techniques | 3 | 2013 | 346 | 0.150 |
Why?
|
| Genetic Linkage | 6 | 1992 | 299 | 0.150 |
Why?
|
| Thermodynamics | 3 | 2009 | 406 | 0.150 |
Why?
|
| Thyroid Hormones | 3 | 2015 | 54 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2001 | 391 | 0.150 |
Why?
|
| Glomerular Mesangium | 1 | 1997 | 18 | 0.150 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2019 | 117 | 0.140 |
Why?
|
| Cardiovascular System | 3 | 2017 | 139 | 0.140 |
Why?
|
| Computational Biology | 3 | 2013 | 598 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2019 | 634 | 0.140 |
Why?
|
| Myocardial Infarction | 2 | 2006 | 1014 | 0.140 |
Why?
|
| Heterozygote | 4 | 2016 | 267 | 0.140 |
Why?
|
| Sciuridae | 3 | 2013 | 145 | 0.140 |
Why?
|
| Hyperalgesia | 3 | 2009 | 109 | 0.140 |
Why?
|
| Laser Capture Microdissection | 1 | 2016 | 22 | 0.140 |
Why?
|
| Automation | 1 | 2017 | 80 | 0.140 |
Why?
|
| Tissue Engineering | 3 | 2005 | 392 | 0.130 |
Why?
|
| Connexins | 5 | 2001 | 53 | 0.130 |
Why?
|
| Cytomegalovirus | 2 | 1995 | 153 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2018 | 501 | 0.130 |
Why?
|
| Contracture | 1 | 2016 | 24 | 0.130 |
Why?
|
| Embryonic Germ Cells | 1 | 2016 | 2 | 0.130 |
Why?
|
| Proteomics | 1 | 2023 | 1010 | 0.130 |
Why?
|
| Benzylamines | 1 | 2016 | 41 | 0.130 |
Why?
|
| Rabbits | 4 | 2008 | 761 | 0.130 |
Why?
|
| Uracil | 1 | 2016 | 30 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 940 | 0.130 |
Why?
|
| Polynucleotides | 1 | 1995 | 14 | 0.130 |
Why?
|
| Peptide Fragments | 4 | 1989 | 686 | 0.130 |
Why?
|
| Response Elements | 1 | 2016 | 89 | 0.130 |
Why?
|
| Fetus | 6 | 1993 | 760 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 1945 | 0.120 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2007 | 141 | 0.120 |
Why?
|
| Pain Management | 3 | 2009 | 320 | 0.120 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2015 | 10 | 0.120 |
Why?
|
| Enzyme Inhibitors | 2 | 2013 | 811 | 0.120 |
Why?
|
| Calmodulin | 3 | 2004 | 75 | 0.120 |
Why?
|
| Biomarkers | 6 | 2022 | 3896 | 0.120 |
Why?
|
| Hybrid Cells | 9 | 1982 | 50 | 0.120 |
Why?
|
| Cell Nucleus | 3 | 2016 | 579 | 0.120 |
Why?
|
| Dystrophin | 2 | 2023 | 34 | 0.120 |
Why?
|
| Snail Family Transcription Factors | 1 | 2015 | 16 | 0.120 |
Why?
|
| Cricetinae | 9 | 2000 | 275 | 0.120 |
Why?
|
| Type C Phospholipases | 1 | 2015 | 72 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 2 | 2015 | 449 | 0.120 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2015 | 47 | 0.120 |
Why?
|
| Cardiomegaly, Exercise-Induced | 1 | 2014 | 3 | 0.120 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2014 | 33 | 0.120 |
Why?
|
| Caseins | 1 | 2014 | 18 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 326 | 0.120 |
Why?
|
| Biophysical Phenomena | 2 | 2009 | 64 | 0.120 |
Why?
|
| Isoenzymes | 6 | 2013 | 304 | 0.120 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 281 | 0.120 |
Why?
|
| Hypertension | 4 | 2011 | 1243 | 0.110 |
Why?
|
| Lipoproteins, VLDL | 1 | 2014 | 22 | 0.110 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2015 | 115 | 0.110 |
Why?
|
| Glucose | 3 | 2014 | 983 | 0.110 |
Why?
|
| Frameshift Mutation | 1 | 1994 | 31 | 0.110 |
Why?
|
| Gene Deletion | 3 | 2005 | 372 | 0.110 |
Why?
|
| Skeletal Muscle Myosins | 1 | 2013 | 1 | 0.110 |
Why?
|
| Lizards | 1 | 2014 | 34 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2012 | 724 | 0.110 |
Why?
|
| Sus scrofa | 1 | 2013 | 46 | 0.110 |
Why?
|
| Oculomotor Muscles | 1 | 2013 | 38 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2007 | 179 | 0.110 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2014 | 190 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2013 | 38 | 0.100 |
Why?
|
| Drug Implants | 1 | 2013 | 82 | 0.100 |
Why?
|
| Volition | 2 | 2003 | 30 | 0.100 |
Why?
|
| DNA Damage | 1 | 2015 | 364 | 0.100 |
Why?
|
| Lung | 3 | 2013 | 3752 | 0.100 |
Why?
|
| Immobilization | 1 | 2013 | 44 | 0.100 |
Why?
|
| Cadherins | 1 | 2014 | 186 | 0.100 |
Why?
|
| Oligonucleotides | 2 | 2005 | 138 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 1990 | 54 | 0.100 |
Why?
|
| Light | 2 | 2012 | 355 | 0.100 |
Why?
|
| Phagosomes | 1 | 2012 | 42 | 0.100 |
Why?
|
| Immediate-Early Proteins | 1 | 2012 | 51 | 0.100 |
Why?
|
| Citrate (si)-Synthase | 2 | 2003 | 58 | 0.100 |
Why?
|
| Hemodynamics | 3 | 2002 | 1084 | 0.100 |
Why?
|
| Genistein | 1 | 2012 | 14 | 0.100 |
Why?
|
| E-Box Elements | 1 | 2012 | 5 | 0.100 |
Why?
|
| Nonmuscle Myosin Type IIB | 2 | 2003 | 7 | 0.100 |
Why?
|
| Ubiquitin | 1 | 2012 | 62 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2012 | 380 | 0.100 |
Why?
|
| Mice, Inbred DBA | 2 | 2011 | 186 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2013 | 180 | 0.100 |
Why?
|
| Aromatase | 1 | 2012 | 31 | 0.100 |
Why?
|
| Muridae | 1 | 1992 | 5 | 0.100 |
Why?
|
| Peptide Termination Factors | 2 | 2003 | 5 | 0.100 |
Why?
|
| Muscular Dystrophies | 1 | 1992 | 39 | 0.100 |
Why?
|
| Electrochemistry | 1 | 2012 | 80 | 0.100 |
Why?
|
| Scattering, Radiation | 1 | 2012 | 97 | 0.100 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 131 | 0.100 |
Why?
|
| Education, Premedical | 1 | 2011 | 4 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2013 | 292 | 0.100 |
Why?
|
| Lysosomes | 1 | 2012 | 136 | 0.100 |
Why?
|
| Autoantigens | 1 | 2015 | 416 | 0.100 |
Why?
|
| Myristic Acids | 1 | 2011 | 7 | 0.100 |
Why?
|
| Rats, Inbred Strains | 6 | 2008 | 356 | 0.100 |
Why?
|
| Surface Plasmon Resonance | 1 | 2012 | 88 | 0.100 |
Why?
|
| Cell Cycle | 4 | 2019 | 581 | 0.100 |
Why?
|
| Elastic Modulus | 1 | 2012 | 123 | 0.100 |
Why?
|
| Molecular Weight | 7 | 2005 | 331 | 0.100 |
Why?
|
| Calcinosis | 2 | 2015 | 232 | 0.100 |
Why?
|
| Insulin | 2 | 2019 | 2320 | 0.100 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 145 | 0.100 |
Why?
|
| School Admission Criteria | 1 | 2011 | 23 | 0.090 |
Why?
|
| Palmitic Acid | 1 | 2011 | 40 | 0.090 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2011 | 51 | 0.090 |
Why?
|
| Movement | 1 | 1994 | 270 | 0.090 |
Why?
|
| Biomimetic Materials | 1 | 2012 | 72 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 137 | 0.090 |
Why?
|
| Program Development | 1 | 2014 | 362 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2013 | 130 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 2739 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 148 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1991 | 29 | 0.090 |
Why?
|
| Educational Measurement | 1 | 2014 | 264 | 0.090 |
Why?
|
| Telomere-Binding Proteins | 1 | 2012 | 102 | 0.090 |
Why?
|
| beta-Adrenergic Receptor Kinases | 2 | 2001 | 6 | 0.090 |
Why?
|
| X Chromosome | 1 | 1991 | 51 | 0.090 |
Why?
|
| Polymorphism, Genetic | 5 | 2020 | 639 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1991 | 52 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2012 | 178 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 179 | 0.090 |
Why?
|
| Fetal Growth Retardation | 1 | 2017 | 543 | 0.090 |
Why?
|
| Heart Failure, Systolic | 1 | 2011 | 25 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2011 | 121 | 0.090 |
Why?
|
| DNA, Complementary | 5 | 1999 | 267 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 269 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2012 | 478 | 0.090 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2011 | 159 | 0.090 |
Why?
|
| Base Pairing | 1 | 2010 | 61 | 0.090 |
Why?
|
| Collagen | 4 | 2004 | 429 | 0.090 |
Why?
|
| Schools, Medical | 1 | 2011 | 131 | 0.090 |
Why?
|
| Cell Movement | 2 | 2013 | 939 | 0.090 |
Why?
|
| Necrosis | 1 | 2011 | 231 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 1 | 2010 | 88 | 0.090 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2010 | 29 | 0.090 |
Why?
|
| DNA Primers | 3 | 2012 | 510 | 0.090 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2007 | 386 | 0.090 |
Why?
|
| SOXD Transcription Factors | 1 | 2010 | 5 | 0.090 |
Why?
|
| Ventricular Function | 2 | 2006 | 60 | 0.090 |
Why?
|
| Restriction Mapping | 6 | 1992 | 74 | 0.090 |
Why?
|
| Telomerase | 1 | 2012 | 231 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 757 | 0.080 |
Why?
|
| Telomere | 1 | 2012 | 226 | 0.080 |
Why?
|
| Phosphates | 1 | 2011 | 168 | 0.080 |
Why?
|
| Conserved Sequence | 3 | 2021 | 228 | 0.080 |
Why?
|
| Resistance Training | 1 | 2012 | 153 | 0.080 |
Why?
|
| Codon, Nonsense | 1 | 2010 | 39 | 0.080 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2009 | 36 | 0.080 |
Why?
|
| Muscle Fibers, Fast-Twitch | 2 | 2001 | 10 | 0.080 |
Why?
|
| Cytoplasm | 3 | 2006 | 258 | 0.080 |
Why?
|
| Crosses, Genetic | 2 | 2006 | 142 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 89 | 0.080 |
Why?
|
| DNA Restriction Enzymes | 7 | 1987 | 53 | 0.080 |
Why?
|
| Pravastatin | 1 | 2009 | 26 | 0.080 |
Why?
|
| Lymphocyte Antigen 96 | 1 | 2009 | 24 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 182 | 0.080 |
Why?
|
| Hypertension, Renal | 1 | 1989 | 16 | 0.080 |
Why?
|
| Superoxide Dismutase | 1 | 2011 | 328 | 0.080 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 500 | 0.080 |
Why?
|
| Molecular Imaging | 1 | 2009 | 55 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2010 | 330 | 0.080 |
Why?
|
| Analgesics, Opioid | 2 | 2009 | 908 | 0.080 |
Why?
|
| Educational Status | 1 | 2011 | 473 | 0.080 |
Why?
|
| Protein Denaturation | 1 | 2009 | 74 | 0.080 |
Why?
|
| Biological Assay | 1 | 2009 | 118 | 0.080 |
Why?
|
| Mollusca | 2 | 1990 | 6 | 0.080 |
Why?
|
| Reference Values | 2 | 2001 | 780 | 0.080 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2010 | 142 | 0.080 |
Why?
|
| Risk Factors | 1 | 2023 | 9769 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2022 | 431 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2008 | 283 | 0.080 |
Why?
|
| Hindlimb | 3 | 2008 | 125 | 0.080 |
Why?
|
| Neuralgia | 2 | 2008 | 120 | 0.080 |
Why?
|
| Mutagenesis | 3 | 2004 | 181 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 242 | 0.070 |
Why?
|
| Caenorhabditis elegans | 1 | 2011 | 291 | 0.070 |
Why?
|
| Sciatic Nerve | 2 | 2006 | 60 | 0.070 |
Why?
|
| Edetic Acid | 1 | 2008 | 46 | 0.070 |
Why?
|
| Myoblasts, Skeletal | 1 | 2008 | 12 | 0.070 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2008 | 59 | 0.070 |
Why?
|
| Transcriptional Activation | 3 | 2006 | 356 | 0.070 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 1987 | 4 | 0.070 |
Why?
|
| Sequence Deletion | 3 | 2015 | 179 | 0.070 |
Why?
|
| Muscle Fibers, Slow-Twitch | 2 | 2013 | 10 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2012 | 1707 | 0.070 |
Why?
|
| Operon | 1 | 1987 | 63 | 0.070 |
Why?
|
| Glutamic Acid | 1 | 2009 | 231 | 0.070 |
Why?
|
| Lipoprotein Lipase | 1 | 2008 | 58 | 0.070 |
Why?
|
| Blotting, Northern | 3 | 2000 | 199 | 0.070 |
Why?
|
| Lasers | 2 | 2023 | 132 | 0.070 |
Why?
|
| Molecular Chaperones | 1 | 2008 | 172 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 1825 | 0.070 |
Why?
|
| Lysine | 1 | 2009 | 278 | 0.070 |
Why?
|
| Genes, Bacterial | 1 | 1987 | 158 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2009 | 263 | 0.070 |
Why?
|
| Bromocriptine | 1 | 2007 | 28 | 0.070 |
Why?
|
| Sequence Tagged Sites | 2 | 2000 | 4 | 0.070 |
Why?
|
| Anoikis | 1 | 2007 | 32 | 0.070 |
Why?
|
| Rats, Wistar | 5 | 1994 | 398 | 0.070 |
Why?
|
| Body Temperature Regulation | 1 | 2008 | 99 | 0.070 |
Why?
|
| Heart Valve Prosthesis | 2 | 2005 | 111 | 0.070 |
Why?
|
| Hormone Replacement Therapy | 1 | 2007 | 91 | 0.070 |
Why?
|
| Probability | 2 | 2023 | 308 | 0.070 |
Why?
|
| Ganglia, Spinal | 1 | 2006 | 50 | 0.070 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2006 | 37 | 0.070 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2006 | 7 | 0.070 |
Why?
|
| Indole Alkaloids | 1 | 2006 | 8 | 0.070 |
Why?
|
| Cold Temperature | 1 | 2008 | 153 | 0.070 |
Why?
|
| Cell Adhesion | 2 | 2005 | 445 | 0.070 |
Why?
|
| Membrane Transport Proteins | 1 | 1987 | 148 | 0.070 |
Why?
|
| Mutagenesis, Insertional | 1 | 2006 | 65 | 0.070 |
Why?
|
| GATA4 Transcription Factor | 1 | 2006 | 18 | 0.070 |
Why?
|
| DNA Mutational Analysis | 3 | 2008 | 386 | 0.060 |
Why?
|
| Major Histocompatibility Complex | 2 | 1989 | 229 | 0.060 |
Why?
|
| Protein Phosphatase 2 | 1 | 2006 | 38 | 0.060 |
Why?
|
| 5' Untranslated Regions | 1 | 2006 | 55 | 0.060 |
Why?
|
| Hyaluronic Acid | 2 | 2005 | 212 | 0.060 |
Why?
|
| Salmonella typhimurium | 1 | 1987 | 176 | 0.060 |
Why?
|
| Temperature | 1 | 2009 | 626 | 0.060 |
Why?
|
| Carbazoles | 1 | 2006 | 84 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2006 | 46 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2009 | 1265 | 0.060 |
Why?
|
| Mice, Inbred mdx | 2 | 2023 | 11 | 0.060 |
Why?
|
| Paclitaxel | 1 | 2006 | 215 | 0.060 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2006 | 124 | 0.060 |
Why?
|
| Zebrafish | 1 | 2010 | 464 | 0.060 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2006 | 186 | 0.060 |
Why?
|
| Postmenopause | 1 | 2007 | 370 | 0.060 |
Why?
|
| Dietary Proteins | 1 | 2006 | 128 | 0.060 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2005 | 4 | 0.060 |
Why?
|
| Sciatica | 1 | 2005 | 8 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2013 | 291 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 413 | 0.060 |
Why?
|
| Bioprosthesis | 1 | 2005 | 39 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2006 | 229 | 0.060 |
Why?
|
| Ku Autoantigen | 1 | 2004 | 13 | 0.060 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2004 | 26 | 0.060 |
Why?
|
| Caspases | 1 | 2006 | 242 | 0.060 |
Why?
|
| Chemokines, CX3C | 1 | 2004 | 11 | 0.060 |
Why?
|
| RNA Splice Sites | 1 | 2004 | 45 | 0.060 |
Why?
|
| Dependovirus | 1 | 2005 | 62 | 0.060 |
Why?
|
| Glycogen | 1 | 2004 | 55 | 0.060 |
Why?
|
| Dogs | 2 | 2023 | 366 | 0.060 |
Why?
|
| Spinal Cord | 4 | 2008 | 354 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2006 | 864 | 0.060 |
Why?
|
| Diacetyl | 1 | 2003 | 7 | 0.060 |
Why?
|
| Catecholamines | 2 | 2022 | 97 | 0.060 |
Why?
|
| Proteoglycans | 2 | 2015 | 109 | 0.050 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2006 | 228 | 0.050 |
Why?
|
| Rats, Inbred Lew | 1 | 2003 | 92 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 889 | 0.050 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2003 | 10 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 3 | 1999 | 94 | 0.050 |
Why?
|
| Isomerism | 1 | 2003 | 48 | 0.050 |
Why?
|
| Interleukin-1 | 2 | 2005 | 961 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 4 | 2003 | 1359 | 0.050 |
Why?
|
| Models, Cardiovascular | 2 | 2014 | 190 | 0.050 |
Why?
|
| Morphine | 1 | 2004 | 129 | 0.050 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2003 | 18 | 0.050 |
Why?
|
| Plant Preparations | 1 | 2003 | 31 | 0.050 |
Why?
|
| Creatine Kinase | 1 | 2003 | 75 | 0.050 |
Why?
|
| DNA Replication | 2 | 2004 | 225 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 2060 | 0.050 |
Why?
|
| Genes, myc | 2 | 2001 | 50 | 0.050 |
Why?
|
| Solubility | 3 | 1994 | 229 | 0.050 |
Why?
|
| Injections | 2 | 1995 | 174 | 0.050 |
Why?
|
| Pandemics | 2 | 2021 | 1492 | 0.050 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2002 | 1 | 0.050 |
Why?
|
| Genomics | 1 | 2008 | 716 | 0.050 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2023 | 19 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 2008 | 437 | 0.050 |
Why?
|
| Myostatin | 2 | 2012 | 18 | 0.050 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2013 | 41 | 0.050 |
Why?
|
| Breath Tests | 1 | 2023 | 89 | 0.050 |
Why?
|
| Pain Threshold | 3 | 2009 | 72 | 0.050 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2002 | 17 | 0.050 |
Why?
|
| Calcimycin | 1 | 2002 | 48 | 0.050 |
Why?
|
| Ionophores | 1 | 2002 | 22 | 0.050 |
Why?
|
| Spectrum Analysis | 1 | 2023 | 86 | 0.050 |
Why?
|
| Muscle Tonus | 1 | 2002 | 19 | 0.050 |
Why?
|
| Electron Transport Complex IV | 1 | 2002 | 57 | 0.050 |
Why?
|
| RNA, Viral | 3 | 2021 | 617 | 0.050 |
Why?
|
| Electron Transport Complex I | 1 | 2002 | 38 | 0.050 |
Why?
|
| Cell Line, Transformed | 2 | 2013 | 140 | 0.050 |
Why?
|
| Space Flight | 1 | 2003 | 122 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2003 | 165 | 0.050 |
Why?
|
| Calcium-Transporting ATPases | 2 | 2000 | 35 | 0.050 |
Why?
|
| H-2 Antigens | 1 | 1982 | 115 | 0.050 |
Why?
|
| Stress, Mechanical | 1 | 2004 | 465 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 3 | 2000 | 706 | 0.050 |
Why?
|
| Oxygen Consumption | 2 | 2002 | 675 | 0.050 |
Why?
|
| Hybridization, Genetic | 1 | 2002 | 80 | 0.050 |
Why?
|
| RNA Splicing Factors | 1 | 2022 | 51 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1993 | 87 | 0.050 |
Why?
|
| RNA, Small Interfering | 3 | 2011 | 571 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2002 | 82 | 0.050 |
Why?
|
| Coloring Agents | 1 | 2002 | 76 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 1987 | 826 | 0.050 |
Why?
|
| NADH Tetrazolium Reductase | 1 | 2001 | 1 | 0.050 |
Why?
|
| Calsequestrin | 1 | 2001 | 8 | 0.050 |
Why?
|
| Blotting, Southern | 2 | 1991 | 68 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 2065 | 0.050 |
Why?
|
| Globins | 2 | 1995 | 21 | 0.050 |
Why?
|
| Calreticulin | 1 | 2001 | 27 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 634 | 0.050 |
Why?
|
| Biological Evolution | 3 | 1994 | 426 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2022 | 313 | 0.050 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2021 | 32 | 0.050 |
Why?
|
| United States | 4 | 2014 | 13940 | 0.050 |
Why?
|
| Adult | 9 | 2020 | 35513 | 0.050 |
Why?
|
| Cell Count | 1 | 2002 | 314 | 0.050 |
Why?
|
| Peptide Chain Termination, Translational | 1 | 2000 | 5 | 0.040 |
Why?
|
| Oligopeptides | 3 | 2012 | 258 | 0.040 |
Why?
|
| RNA Polymerase III | 4 | 1985 | 26 | 0.040 |
Why?
|
| Chromatography, Gel | 2 | 1991 | 127 | 0.040 |
Why?
|
| Xenopus Proteins | 1 | 2000 | 35 | 0.040 |
Why?
|
| Virion | 1 | 2021 | 85 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2001 | 89 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2002 | 236 | 0.040 |
Why?
|
| Triiodothyronine | 2 | 1991 | 44 | 0.040 |
Why?
|
| Autoimmune Diseases | 2 | 1995 | 425 | 0.040 |
Why?
|
| Tropomyosin | 1 | 2000 | 12 | 0.040 |
Why?
|
| Cyclosporine | 1 | 2001 | 169 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1991 | 323 | 0.040 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2000 | 15 | 0.040 |
Why?
|
| Homozygote | 1 | 2001 | 193 | 0.040 |
Why?
|
| Endothelial Growth Factors | 1 | 2000 | 51 | 0.040 |
Why?
|
| Macromolecular Substances | 2 | 1991 | 211 | 0.040 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2001 | 71 | 0.040 |
Why?
|
| Membrane Potentials | 2 | 1991 | 260 | 0.040 |
Why?
|
| Lymphokines | 1 | 2000 | 115 | 0.040 |
Why?
|
| Systole | 2 | 2015 | 191 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 97 | 0.040 |
Why?
|
| RNA Polymerase II | 3 | 1992 | 317 | 0.040 |
Why?
|
| Epitopes | 4 | 1996 | 466 | 0.040 |
Why?
|
| Tacrolimus | 1 | 2001 | 140 | 0.040 |
Why?
|
| Tongue | 1 | 2000 | 71 | 0.040 |
Why?
|
| Homeostasis | 2 | 2014 | 605 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2021 | 165 | 0.040 |
Why?
|
| Capsid | 2 | 2000 | 91 | 0.040 |
Why?
|
| Materials Testing | 3 | 2007 | 346 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2001 | 339 | 0.040 |
Why?
|
| Mice, Inbred CBA | 1 | 1999 | 52 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 317 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2009 | 2267 | 0.040 |
Why?
|
| In Situ Hybridization | 2 | 1999 | 292 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2000 | 232 | 0.040 |
Why?
|
| Elasticity | 2 | 2013 | 200 | 0.040 |
Why?
|
| Aortic Valve Stenosis | 1 | 2022 | 218 | 0.040 |
Why?
|
| Genes, Viral | 2 | 1992 | 81 | 0.040 |
Why?
|
| Peptide Hydrolases | 2 | 1986 | 106 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2001 | 330 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 368 | 0.040 |
Why?
|
| Dipeptidases | 1 | 1978 | 1 | 0.040 |
Why?
|
| Lyases | 1 | 1978 | 9 | 0.040 |
Why?
|
| HeLa Cells | 3 | 2012 | 607 | 0.040 |
Why?
|
| Lactoylglutathione Lyase | 1 | 1978 | 17 | 0.040 |
Why?
|
| Endothelium, Vascular | 3 | 2002 | 872 | 0.040 |
Why?
|
| Cross-Linking Reagents | 3 | 2005 | 206 | 0.040 |
Why?
|
| Pulmonary Fibrosis | 1 | 2002 | 378 | 0.040 |
Why?
|
| Fibronectins | 2 | 2012 | 120 | 0.040 |
Why?
|
| Triose-Phosphate Isomerase | 1 | 1978 | 1 | 0.040 |
Why?
|
| Carbohydrate Epimerases | 1 | 1978 | 2 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2013 | 1271 | 0.040 |
Why?
|
| Diaphragm | 1 | 1998 | 43 | 0.040 |
Why?
|
| Adenosine Kinase | 1 | 1978 | 2 | 0.040 |
Why?
|
| Species Specificity | 3 | 1995 | 570 | 0.040 |
Why?
|
| Phosphotransferases | 1 | 1978 | 24 | 0.040 |
Why?
|
| Cytoplasmic Granules | 1 | 1998 | 78 | 0.040 |
Why?
|
| Albumins | 1 | 1978 | 101 | 0.040 |
Why?
|
| Deoxyadenosines | 1 | 1977 | 8 | 0.040 |
Why?
|
| Permeability | 1 | 2018 | 156 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 1997 | 33 | 0.040 |
Why?
|
| Dactinomycin | 1 | 1977 | 30 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 1210 | 0.040 |
Why?
|
| Phylogeny | 1 | 2021 | 846 | 0.030 |
Why?
|
| Karyotyping | 5 | 1986 | 107 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2022 | 701 | 0.030 |
Why?
|
| Detergents | 2 | 2001 | 45 | 0.030 |
Why?
|
| Back | 1 | 2016 | 11 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 690 | 0.030 |
Why?
|
| Crystallization | 1 | 1997 | 137 | 0.030 |
Why?
|
| Research Design | 1 | 2002 | 1040 | 0.030 |
Why?
|
| Autoantibodies | 2 | 1995 | 1465 | 0.030 |
Why?
|
| Pain | 3 | 2009 | 760 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1997 | 125 | 0.030 |
Why?
|
| Students | 1 | 2021 | 574 | 0.030 |
Why?
|
| Chromosome Deletion | 2 | 1994 | 102 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 1875 | 0.030 |
Why?
|
| Neck | 1 | 2016 | 92 | 0.030 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 26 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 1997 | 177 | 0.030 |
Why?
|
| Peer Review, Research | 1 | 1996 | 41 | 0.030 |
Why?
|
| Microinjections | 2 | 2006 | 76 | 0.030 |
Why?
|
| Middle Aged | 5 | 2020 | 31080 | 0.030 |
Why?
|
| Bacteria | 1 | 2002 | 811 | 0.030 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2015 | 17 | 0.030 |
Why?
|
| Sp7 Transcription Factor | 1 | 2015 | 7 | 0.030 |
Why?
|
| Growth Hormone | 1 | 1995 | 96 | 0.030 |
Why?
|
| Pliability | 1 | 2015 | 46 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 1998 | 780 | 0.030 |
Why?
|
| Fetal Heart | 1 | 1996 | 55 | 0.030 |
Why?
|
| Osteocalcin | 1 | 2015 | 36 | 0.030 |
Why?
|
| Capsid Proteins | 1 | 1996 | 91 | 0.030 |
Why?
|
| Models, Genetic | 1 | 1998 | 591 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 1997 | 1000 | 0.030 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2006 | 223 | 0.030 |
Why?
|
| Pain Measurement | 2 | 2009 | 487 | 0.030 |
Why?
|
| Tissue Donors | 1 | 1997 | 388 | 0.030 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 1985 | 28 | 0.030 |
Why?
|
| Hot Temperature | 2 | 2009 | 364 | 0.030 |
Why?
|
| Antioxidants | 1 | 2018 | 543 | 0.030 |
Why?
|
| Thiazolidinediones | 1 | 2015 | 137 | 0.030 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1994 | 10 | 0.030 |
Why?
|
| RNA Probes | 1 | 1994 | 13 | 0.030 |
Why?
|
| Hypertension, Renovascular | 1 | 1994 | 13 | 0.030 |
Why?
|
| Sheep | 1 | 2017 | 829 | 0.030 |
Why?
|
| Hyperthyroidism | 1 | 1994 | 28 | 0.030 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2014 | 101 | 0.030 |
Why?
|
| Surface Properties | 2 | 2005 | 394 | 0.030 |
Why?
|
| Heart Conduction System | 1 | 2014 | 94 | 0.030 |
Why?
|
| Stage-Specific Embryonic Antigens | 1 | 2013 | 2 | 0.030 |
Why?
|
| Polystyrenes | 1 | 2013 | 38 | 0.030 |
Why?
|
| Fetal Development | 1 | 2017 | 283 | 0.030 |
Why?
|
| Safety | 1 | 1995 | 329 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 348 | 0.030 |
Why?
|
| Cardiology | 1 | 1996 | 267 | 0.030 |
Why?
|
| Mass Screening | 1 | 2021 | 1159 | 0.030 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2013 | 56 | 0.030 |
Why?
|
| Optical Tweezers | 1 | 2013 | 21 | 0.030 |
Why?
|
| Immune System | 1 | 1994 | 177 | 0.030 |
Why?
|
| Chemotaxis | 1 | 1994 | 130 | 0.030 |
Why?
|
| Muscular Diseases | 2 | 2008 | 110 | 0.030 |
Why?
|
| Birefringence | 1 | 1993 | 6 | 0.030 |
Why?
|
| Liver Cirrhosis, Experimental | 1 | 1993 | 11 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2013 | 139 | 0.030 |
Why?
|
| Registries | 1 | 2020 | 1884 | 0.030 |
Why?
|
| Starvation | 1 | 2012 | 22 | 0.030 |
Why?
|
| DNA Probes | 2 | 1989 | 61 | 0.030 |
Why?
|
| Vasodilator Agents | 2 | 2006 | 322 | 0.030 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2012 | 24 | 0.020 |
Why?
|
| Aged | 4 | 2020 | 22090 | 0.020 |
Why?
|
| Acrylates | 1 | 2012 | 45 | 0.020 |
Why?
|
| Transplantation | 1 | 1992 | 25 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 434 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 1993 | 324 | 0.020 |
Why?
|
| Societies, Medical | 1 | 1996 | 749 | 0.020 |
Why?
|
| Leukemia Virus, Murine | 2 | 1985 | 17 | 0.020 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1992 | 4 | 0.020 |
Why?
|
| Cell Separation | 1 | 2013 | 313 | 0.020 |
Why?
|
| Macrophages | 2 | 2009 | 1466 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 493 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 182 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2012 | 118 | 0.020 |
Why?
|
| Primary Cell Culture | 1 | 2012 | 159 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 3033 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2013 | 178 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2013 | 182 | 0.020 |
Why?
|
| Connexin 26 | 1 | 1991 | 8 | 0.020 |
Why?
|
| Hospitalization | 1 | 2021 | 2077 | 0.020 |
Why?
|
| Antigens | 1 | 2013 | 353 | 0.020 |
Why?
|
| Histone Deacetylase 6 | 1 | 2011 | 19 | 0.020 |
Why?
|
| Biology | 1 | 1992 | 83 | 0.020 |
Why?
|
| Sarcosine | 1 | 1991 | 10 | 0.020 |
Why?
|
| Densitometry | 1 | 1991 | 33 | 0.020 |
Why?
|
| Adipocytes | 1 | 1993 | 204 | 0.020 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1991 | 13 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 387 | 0.020 |
Why?
|
| Colorado | 1 | 2021 | 4396 | 0.020 |
Why?
|
| Wnt Signaling Pathway | 1 | 2012 | 166 | 0.020 |
Why?
|
| Buffers | 1 | 1991 | 55 | 0.020 |
Why?
|
| Inflammation | 3 | 2008 | 2668 | 0.020 |
Why?
|
| Ultracentrifugation | 1 | 1991 | 48 | 0.020 |
Why?
|
| Hypothyroidism | 1 | 1991 | 71 | 0.020 |
Why?
|
| Deoxyribonuclease I | 1 | 1990 | 38 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 83 | 0.020 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1991 | 58 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 245 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 307 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2006 | 758 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1990 | 41 | 0.020 |
Why?
|
| Embryo, Mammalian | 2 | 1989 | 226 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 1990 | 98 | 0.020 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1989 | 4 | 0.020 |
Why?
|
| Adolescent | 3 | 2014 | 20302 | 0.020 |
Why?
|
| Infusion Pumps | 1 | 2009 | 31 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2013 | 722 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2011 | 206 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 441 | 0.020 |
Why?
|
| Receptors, Opioid, mu | 1 | 2009 | 57 | 0.020 |
Why?
|
| Heart Atria | 1 | 1990 | 127 | 0.020 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2008 | 6 | 0.020 |
Why?
|
| Myelin Proteins | 1 | 2008 | 44 | 0.020 |
Why?
|
| Analgesia | 1 | 2009 | 92 | 0.020 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2008 | 49 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1992 | 525 | 0.020 |
Why?
|
| Pedigree | 2 | 2006 | 486 | 0.020 |
Why?
|
| Naloxone | 1 | 2009 | 113 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2008 | 93 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1988 | 43 | 0.020 |
Why?
|
| Heart-Assist Devices | 1 | 2014 | 537 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 1994 | 1924 | 0.020 |
Why?
|
| Biotechnology | 1 | 1988 | 40 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 1987 | 72 | 0.020 |
Why?
|
| Paralysis | 1 | 2008 | 72 | 0.020 |
Why?
|
| Adiposity | 1 | 2012 | 505 | 0.020 |
Why?
|
| Reaction Time | 1 | 2009 | 409 | 0.020 |
Why?
|
| Lymphoma | 2 | 1986 | 194 | 0.020 |
Why?
|
| Narcotic Antagonists | 1 | 2009 | 162 | 0.020 |
Why?
|
| Vinculin | 1 | 2007 | 10 | 0.020 |
Why?
|
| Birds | 1 | 2008 | 74 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2007 | 43 | 0.020 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2009 | 171 | 0.020 |
Why?
|
| Receptors, Virus | 2 | 1996 | 83 | 0.020 |
Why?
|
| Body Temperature | 1 | 2008 | 216 | 0.020 |
Why?
|
| Pulmonary Heart Disease | 1 | 2006 | 6 | 0.020 |
Why?
|
| Eisenmenger Complex | 1 | 2006 | 10 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2008 | 228 | 0.020 |
Why?
|
| Hyperesthesia | 1 | 2006 | 7 | 0.020 |
Why?
|
| Bacteriophage lambda | 1 | 1987 | 88 | 0.020 |
Why?
|
| DNA, Concatenated | 1 | 2006 | 1 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2006 | 59 | 0.020 |
Why?
|
| Syndactyly | 1 | 2006 | 10 | 0.020 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2006 | 51 | 0.020 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2006 | 24 | 0.020 |
Why?
|
| Transposases | 1 | 2006 | 16 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2006 | 26 | 0.020 |
Why?
|
| Ligation | 1 | 2006 | 87 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2013 | 1192 | 0.020 |
Why?
|
| Kidney | 1 | 1993 | 1308 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2006 | 77 | 0.020 |
Why?
|
| Chromosomes, Human, 13-15 | 1 | 1986 | 1 | 0.020 |
Why?
|
| Meninges | 1 | 2006 | 43 | 0.020 |
Why?
|
| Neutralization Tests | 2 | 1996 | 73 | 0.020 |
Why?
|
| Chick Embryo | 1 | 1986 | 130 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1986 | 69 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2005 | 17 | 0.020 |
Why?
|
| Epoprostenol | 1 | 2006 | 134 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2005 | 49 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2006 | 148 | 0.020 |
Why?
|
| Neuroglia | 1 | 2006 | 167 | 0.020 |
Why?
|
| Pressure | 1 | 2006 | 240 | 0.020 |
Why?
|
| DNA, Circular | 1 | 1985 | 15 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2006 | 99 | 0.020 |
Why?
|
| Haplorhini | 1 | 1985 | 50 | 0.020 |
Why?
|
| Child | 3 | 2014 | 20806 | 0.020 |
Why?
|
| Rodentia | 1 | 1985 | 47 | 0.020 |
Why?
|
| Zymosan | 1 | 2005 | 65 | 0.020 |
Why?
|
| AKR murine leukemia virus | 1 | 1985 | 1 | 0.020 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2005 | 24 | 0.020 |
Why?
|
| Trisomy | 1 | 1986 | 77 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 12389 | 0.020 |
Why?
|
| Thiazoles | 1 | 2005 | 115 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2006 | 230 | 0.010 |
Why?
|
| Elastin | 1 | 2005 | 78 | 0.010 |
Why?
|
| Compressive Strength | 1 | 2005 | 71 | 0.010 |
Why?
|
| Thymus Neoplasms | 1 | 1985 | 22 | 0.010 |
Why?
|
| Software | 1 | 1990 | 610 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 1985 | 27 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2009 | 941 | 0.010 |
Why?
|
| Forecasting | 1 | 2006 | 358 | 0.010 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2004 | 20 | 0.010 |
Why?
|
| Calcium Channels, L-Type | 1 | 2006 | 113 | 0.010 |
Why?
|
| Receptors, HIV | 1 | 2004 | 26 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2006 | 231 | 0.010 |
Why?
|
| Chemokine CX3CL1 | 1 | 2004 | 23 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 2004 | 35 | 0.010 |
Why?
|
| Laminin | 1 | 2004 | 69 | 0.010 |
Why?
|
| Interleukin-1beta | 1 | 2006 | 374 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 309 | 0.010 |
Why?
|
| Nucleic Acid Denaturation | 1 | 1984 | 32 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 2004 | 83 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 2004 | 152 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2005 | 218 | 0.010 |
Why?
|
| Exercise Test | 1 | 2007 | 615 | 0.010 |
Why?
|
| Chromosomes, Human, 16-18 | 1 | 1983 | 4 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2006 | 177 | 0.010 |
Why?
|
| Diastole | 1 | 2003 | 151 | 0.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2004 | 250 | 0.010 |
Why?
|
| Plectin | 1 | 2003 | 2 | 0.010 |
Why?
|
| Tyrosine Transaminase | 2 | 1983 | 3 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2009 | 805 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2004 | 466 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 14571 | 0.010 |
Why?
|
| Antibodies, Antinuclear | 1 | 2003 | 66 | 0.010 |
Why?
|
| Intermediate Filament Proteins | 1 | 2003 | 57 | 0.010 |
Why?
|
| Systems Analysis | 1 | 2002 | 22 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2003 | 106 | 0.010 |
Why?
|
| Hormones | 1 | 1983 | 140 | 0.010 |
Why?
|
| Glycoproteins | 2 | 1982 | 337 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2003 | 182 | 0.010 |
Why?
|
| RNA, Small Nuclear | 1 | 1982 | 36 | 0.010 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 1982 | 3 | 0.010 |
Why?
|
| Half-Life | 1 | 1982 | 144 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2002 | 102 | 0.010 |
Why?
|
| Organizational Policy | 1 | 2002 | 76 | 0.010 |
Why?
|
| Ion Channels | 1 | 2002 | 127 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1982 | 150 | 0.010 |
Why?
|
| Potassium | 1 | 2002 | 138 | 0.010 |
Why?
|
| Clone Cells | 2 | 1983 | 255 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2002 | 113 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 2002 | 128 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2006 | 1192 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2005 | 490 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 2001 | 43 | 0.010 |
Why?
|
| Advisory Committees | 1 | 2002 | 220 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 2000 | 23 | 0.010 |
Why?
|
| Templates, Genetic | 1 | 2000 | 61 | 0.010 |
Why?
|
| Molecular Mimicry | 1 | 2000 | 37 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 2001 | 137 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2000 | 97 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2000 | 65 | 0.010 |
Why?
|
| GTP Phosphohydrolases | 1 | 2000 | 84 | 0.010 |
Why?
|
| Wound Healing | 1 | 2002 | 311 | 0.010 |
Why?
|
| Acidosis | 1 | 2001 | 88 | 0.010 |
Why?
|
| Hyperemia | 1 | 2000 | 48 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2002 | 417 | 0.010 |
Why?
|
| RNA Stability | 1 | 2000 | 100 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 10451 | 0.010 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1979 | 20 | 0.010 |
Why?
|
| Ouabain | 1 | 1979 | 18 | 0.010 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1979 | 40 | 0.010 |
Why?
|
| Peptides | 1 | 2004 | 911 | 0.010 |
Why?
|
| Electrophoresis, Starch Gel | 1 | 1978 | 1 | 0.010 |
Why?
|
| Alcohol Oxidoreductases | 1 | 1978 | 49 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1979 | 163 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 1978 | 149 | 0.010 |
Why?
|
| Aminopeptidases | 1 | 1978 | 14 | 0.010 |
Why?
|
| DNA, Viral | 2 | 1996 | 348 | 0.010 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 1997 | 3 | 0.010 |
Why?
|
| Myeloma Proteins | 1 | 1977 | 14 | 0.010 |
Why?
|
| Tobacco Mosaic Virus | 1 | 1977 | 3 | 0.010 |
Why?
|
| Triticum | 1 | 1977 | 11 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1977 | 47 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1977 | 62 | 0.010 |
Why?
|
| Reticulocytes | 1 | 1977 | 18 | 0.010 |
Why?
|
| Kyphosis | 1 | 1997 | 36 | 0.010 |
Why?
|
| Growth Disorders | 1 | 1997 | 80 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 1977 | 87 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 1997 | 85 | 0.010 |
Why?
|
| Muscle Weakness | 1 | 1997 | 85 | 0.010 |
Why?
|
| Methionine | 1 | 1977 | 157 | 0.010 |
Why?
|
| Communication | 1 | 2002 | 840 | 0.010 |
Why?
|
| Proteins | 1 | 1982 | 936 | 0.010 |
Why?
|
| Serotyping | 1 | 1996 | 28 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1977 | 538 | 0.010 |
Why?
|
| Methylcholanthrene | 2 | 1986 | 21 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 2006 | 1741 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2002 | 1735 | 0.010 |
Why?
|
| Goals | 1 | 1996 | 162 | 0.010 |
Why?
|
| Fetal Proteins | 1 | 1994 | 16 | 0.010 |
Why?
|
| Succinate Dehydrogenase | 1 | 1994 | 43 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1995 | 347 | 0.010 |
Why?
|
| Neurons | 1 | 2002 | 1456 | 0.010 |
Why?
|
| Stroke | 1 | 2002 | 1067 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1995 | 141 | 0.010 |
Why?
|
| Growth Substances | 2 | 1984 | 151 | 0.010 |
Why?
|
| Thyroxine | 1 | 1994 | 62 | 0.010 |
Why?
|
| Glutamine | 1 | 1994 | 92 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1996 | 349 | 0.010 |
Why?
|
| Culture Media | 2 | 1984 | 167 | 0.010 |
Why?
|
| Carbon Tetrachloride Poisoning | 1 | 1993 | 2 | 0.010 |
Why?
|
| Cation Transport Proteins | 1 | 1994 | 129 | 0.010 |
Why?
|
| Arginine | 1 | 1994 | 259 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1996 | 603 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1995 | 846 | 0.010 |
Why?
|
| Publishing | 1 | 1992 | 141 | 0.010 |
Why?
|
| Heart Rate | 1 | 1994 | 808 | 0.010 |
Why?
|
| Obesity | 1 | 2002 | 2863 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1989 | 81 | 0.000 |
Why?
|
| Rats, Inbred F344 | 1 | 1989 | 251 | 0.000 |
Why?
|
| Phosphothreonine | 1 | 1987 | 6 | 0.000 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 1987 | 20 | 0.000 |
Why?
|
| Caenorhabditis | 1 | 1986 | 3 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1997 | 3383 | 0.000 |
Why?
|
| Mice, Inbred AKR | 1 | 1985 | 34 | 0.000 |
Why?
|
| Liver Regeneration | 1 | 1984 | 40 | 0.000 |
Why?
|
| Glucuronosyltransferase | 1 | 1983 | 13 | 0.000 |
Why?
|
| Gels | 1 | 1983 | 83 | 0.000 |
Why?
|
| Blood | 1 | 1983 | 100 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1994 | 7066 | 0.000 |
Why?
|
| Tubulin | 1 | 1983 | 138 | 0.000 |
Why?
|
| Cricetulus | 1 | 1981 | 104 | 0.000 |
Why?
|
| CHO Cells | 1 | 1981 | 150 | 0.000 |
Why?
|
| RNA, Heterogeneous Nuclear | 1 | 1980 | 4 | 0.000 |
Why?
|
| Simian virus 40 | 1 | 1980 | 24 | 0.000 |
Why?
|
| Replicon | 1 | 1980 | 14 | 0.000 |
Why?
|
| BK Virus | 1 | 1980 | 13 | 0.000 |
Why?
|
| Viral Proteins | 1 | 1978 | 321 | 0.000 |
Why?
|
| Virus Replication | 1 | 1978 | 444 | 0.000 |
Why?
|